Can Gene Therapy Cure Blindness?
Since the approval of the first gene therapy for blindness, there has been a wave…
10/03/2021 - 7 minutes
GenSight Biologics
Get to Know 15 Awesome Biotechs in Paris
Paris attracts millions of tourists to see some of the world’s most iconic monuments: the…
18/02/2020 - 12 minutes
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage…
17/10/2019 - 2 minutes
After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy
The French biotech GenSight will apply for regulatory approval for its gene therapy despite the…
29/05/2019 - 2 minutes
Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial
GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly…
04/04/2018 - 2 minutes
This Gene Therapy for Vision Loss is Safe and Effective After Two Years
The results of a long-term follow-up suggest that GenSight's gene therapy for Leber hereditary optic…
20/02/2018 - 3 minutes
French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa
GenSight will start a clinical trial in the UK testing a combination of gene therapy…
10/01/2018 - 2 minutes
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
09/01/2018 - 5 minutes
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
18/12/2017 - 9 minutes
Update: French Gene Therapy Yields Longer Term Sight Restoration, Eyes Phase III
Update (05/12/2017): GenSight has reported a sustained effect of its treatment GS010, which has now…
05/12/2017 - 3 minutes
Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix…
28/11/2017 - 8 minutes
French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight
Gensight Biologics has announced a capital increase that totals €22.5M and will support the launch…
23/06/2017 - 1 minute
